GlassScriptPhysician profile
Lori A Turner
NPI 1477933810
$6,347.10
in general payments reported to CMS, 2019-2025
57 companies · $2,210 in 2025
The $2,210 reported for 2025 was more than what 94% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.96 · 2023: $1,484 · 2024: $2,607 · 2025: $2,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,301.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $737.76 | 2023-2025 | Rexulti |
| Abbvie INC. | $614.56 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $537.16 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $328.57 | 2023-2025 | |
| Novo Nordisk INC | $321.01 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Axsome Therapeutics, INC. | $303.28 | 2023-2025 | Sunosi, Auvelity |
| Lundbeck LLC | $284.28 | 2023-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $266.47 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Sumitomo Pharma America, INC. | $194.72 | 2024-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.92 | 2023-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $172.00 | 2024-2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $155.25 | 2023-2025 | Caplyta |
| Ardelyx, INC. | $122.27 | 2024-2025 | Ibsrela |
| Dexcom, INC. | $121.22 | 2023-2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $118.68 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $104.67 | 2023-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $104.62 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Esperion Therapeutics, INC. | $103.45 | 2023-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $83.45 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.08 | 2024-2025 | Xifaxan |
| Impel Pharmaceuticals INC. | $73.60 | 2023 | Trudhesa |
| Bayer Healthcare Pharmaceuticals INC. | $69.97 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $69.28 | 2024-2025 | Verquvo, Capvaxive |
| Argenx US, INC. | $68.66 | 2022-2023 | Vyvgart |
| Corcept Therapeutics | $67.92 | 2024-2025 | Korlym |
| Acadia Pharmaceuticals INC | $66.68 | 2023 | Nuplazid |
| Vanda Pharmaceuticals INC. | $59.10 | 2024-2025 | Fanapt, Hetlioz |
| Kowa Pharmaceuticals America, INC. | $58.52 | 2024-2025 | Zoryve, Livalo |
| Phathom Pharmaceuticals, INC. | $55.00 | 2023-2025 | Voquezna |
| Astellas Pharma US INC | $52.59 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $51.58 | 2024-2025 | |
| Eisai INC. | $50.29 | 2023-2024 | |
| Azurity Pharmaceuticals, INC. | $48.94 | 2024-2025 | Horizant, Azmiro, Alvesco |
| Alexion Pharmaceuticals, INC. | $45.98 | 2023 | Ultomiris |
| Alnylam Pharmaceuticals INC. | $44.65 | 2022-2023 | Onpattro |
| Antares Pharma, INC. | $42.40 | 2024 | Xyosted |
| Neurelis, INC. | $36.61 | 2023 | Valtoco |
| Neurocrine Biosciences, INC. | $36.25 | 2023 | Ingrezza, Ongentys |
| Genzyme Corporation | $33.96 | 2024 | |
| Sanofi Pasteur INC. | $32.73 | 2025 | |
| Ani Pharmaceuticals, INC. | $32.54 | 2023 | Purified Cortrophin Gel |
| Sk Life Science, INC. | $30.90 | 2023 | |
| Verrica Pharmaceuticals INC. | $28.53 | 2025 | Ycanth |
| Acorda Therapeutics, INC | $24.26 | 2023 | Inbrija |
| Xeris Pharmaceuticals, INC. | $23.84 | 2024 | Recorlev |
| Tg Therapeutics, INC. | $21.28 | 2023 | |
| Sanofi-Aventis U.S. LLC | $20.23 | 2023 | |
| Tris Pharma INC | $18.49 | 2024 | Dyanavel Xr |
| Hospira, INC. | $18.37 | 2023 | |
| Genentech USA, INC. | $17.80 | 2023 | Enspryng, Ocrevus |
| Cvrx, INC. | $17.60 | 2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $17.00 | 2024 | Xarelto |
| Medtronic, INC. | $16.66 | 2023 | Intellis Adaptivestim |
| Ucb, INC. | $16.39 | 2023 | Fintepla |
| Abiomed | $15.87 | 2024 | Impella |
| Teva Pharmaceuticals USA, INC. | $13.22 | 2023 | Austedo |
| Organon LLC | $11.99 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.